Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Efficacy”

49,980 trials

Showing 20 of 49,980 results

Testing effectiveness (Phase 2)Study completedNCT05197556
What this trial is testing

Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients

Who this might be right for
Obesity
Glaceum 81
Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Testing effectiveness (Phase 2)Study completedNCT05309629
What this trial is testing

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 40
Large-scale testing (Phase 3)Study completedNCT00298831
What this trial is testing

Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)

Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 224
Testing effectiveness (Phase 2)Study completedNCT01839331
What this trial is testing

An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee

Who this might be right for
Osteoarthritis of the Knee
Ampio Pharmaceuticals. Inc. 329
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Post-approval studies (Phase 4)Ended earlyNCT01512472
What this trial is testing

Firmagon (Degarelix) Intermittent Therapy

Who this might be right for
Prostate Cancer Recurrent
Canadian Urology Research Consortium 144
Post-approval studies (Phase 4)Study completedNCT02866695
What this trial is testing

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Who this might be right for
Actinic Keratosis
University of California, San Francisco 20
Testing effectiveness (Phase 2)Study completedNCT01332695
What this trial is testing

A Pilot Efficacy and Safety Study of ST101 in Essential Tremor

Who this might be right for
Essential Tremor
Sonexa Therapeutics, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT01271777
What this trial is testing

Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity

Who this might be right for
Insulin ResistanceAbdominal Obesity
Genfit 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05199077
What this trial is testing

GM-XANTHO in Pressure Ulcer Patients

Who this might be right for
Pressure UlcerDiabetes Mellitus
Xantho Biotechnology Co., LTD 58
Not applicableStudy completedNCT02137577
What this trial is testing

AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China

Who this might be right for
Peripheral Artery Disease
Acotec Scientific Co., Ltd 120
Large-scale testing (Phase 3)Study completedNCT00246701
What this trial is testing

Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects

Who this might be right for
Hypertriglyceridemia
GlaxoSmithKline 256
Testing effectiveness (Phase 2)Study completedNCT03976401
What this trial is testing

Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc 110
Testing effectiveness (Phase 2)Study completedNCT03640312
What this trial is testing

Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension

Who this might be right for
Hypertension
Washington University School of Medicine 62
Testing effectiveness (Phase 2)Ended earlyNCT00701181
What this trial is testing

Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema

Who this might be right for
Diabetic RetinopathyDiabetes Complications
Quark Pharmaceuticals 184
Testing effectiveness (Phase 2)Study completedNCT01928381
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability

Who this might be right for
Diabetic Neuropathy, Painful; Diabetic Neuropathies
AstraZeneca 150
Testing effectiveness (Phase 2)Looking for participantsNCT06173219
What this trial is testing

Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

Who this might be right for
Advanced Solid Tumor
China-Japan Friendship Hospital 38
Large-scale testing (Phase 3)Study completedNCT02314819
What this trial is testing

A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO)

Who this might be right for
Colorectal Cancer
Hutchison Medipharma Limited 416
Early research (Phase 1)Ended earlyNCT00290719
What this trial is testing

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 6
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation